Cargando…
Zolpidem Activation of Alpha 1-Containing GABA(A) Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons
Introduction: High frequency neuronal activity in the cerebral cortex can be induced by noxious stimulation during surgery, brain injury or poisoning. In this scenario, it is essential to block cortical hyperactivity to protect the brain against damage, e.g., by using drugs that act as positive allo...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333667/ https://www.ncbi.nlm.nih.gov/pubmed/30687091 http://dx.doi.org/10.3389/fphar.2018.01523 |
_version_ | 1783387594220896256 |
---|---|
author | Neumann, Elena Rudolph, Uwe Knutson, Daniel E. Li, Guanguan Cook, James M. Hentschke, Harald Antkowiak, Bernd Drexler, Berthold |
author_facet | Neumann, Elena Rudolph, Uwe Knutson, Daniel E. Li, Guanguan Cook, James M. Hentschke, Harald Antkowiak, Bernd Drexler, Berthold |
author_sort | Neumann, Elena |
collection | PubMed |
description | Introduction: High frequency neuronal activity in the cerebral cortex can be induced by noxious stimulation during surgery, brain injury or poisoning. In this scenario, it is essential to block cortical hyperactivity to protect the brain against damage, e.g., by using drugs that act as positive allosteric modulators at GABA(A) receptors. Yet, cortical neurons express multiple, functionally distinct GABA(A) receptor subtypes. Currently there is a lack of knowledge which GABA(A) receptor subtypes would be a good pharmacological target to reduce extensive cortical activity. Methods: Spontaneous action potential activity was monitored by performing extracellular recordings from organotypic neocortical slice cultures of wild type and GABA(A)R-α1(H101R) mutant mice. Phases of high neuronal activity were characterized using peri-event time histograms. Drug effects on within-up state firing rates were quantified via Hedges’ g. Results: We quantified the effects of zolpidem, a positive modulator of GABA(A) receptors harboring α1-subunits, and the experimental benzodiazepine SH-053-2′F-S-CH3, which preferably acts at α2/3/5- but spares α1-subunits. Both agents decreased spontaneous action potential activity but altered the firing patterns in different ways. Zolpidem reduced action potential firing during highly active network states. This action was abolished by flumazenil, suggesting that it was mediated by benzodiazepine-sensitive GABA(A) receptors. SH-053-2′F-S-CH3 also attenuated neuronal activity, but unlike zolpidem, failed to reduce high frequency firing. To confirm that zolpidem actions were indeed mediated via α1-dependent actions, it was evaluated in slices from wild type and α(H101R) knock-in mice. Inhibition of high frequency action potential firing was observed in slices from wild type but not mutant mice. Conclusion: Our results suggest that during episodes of scarce and high neuronal activity action potential firing of cortical neurons is controlled by different GABA(A) receptor subtypes. Exaggerated firing of cortical neurons is reduced by positive modulation of α1-, but not α2/3/5-subunit containing GABA(A) receptors. |
format | Online Article Text |
id | pubmed-6333667 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63336672019-01-25 Zolpidem Activation of Alpha 1-Containing GABA(A) Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons Neumann, Elena Rudolph, Uwe Knutson, Daniel E. Li, Guanguan Cook, James M. Hentschke, Harald Antkowiak, Bernd Drexler, Berthold Front Pharmacol Pharmacology Introduction: High frequency neuronal activity in the cerebral cortex can be induced by noxious stimulation during surgery, brain injury or poisoning. In this scenario, it is essential to block cortical hyperactivity to protect the brain against damage, e.g., by using drugs that act as positive allosteric modulators at GABA(A) receptors. Yet, cortical neurons express multiple, functionally distinct GABA(A) receptor subtypes. Currently there is a lack of knowledge which GABA(A) receptor subtypes would be a good pharmacological target to reduce extensive cortical activity. Methods: Spontaneous action potential activity was monitored by performing extracellular recordings from organotypic neocortical slice cultures of wild type and GABA(A)R-α1(H101R) mutant mice. Phases of high neuronal activity were characterized using peri-event time histograms. Drug effects on within-up state firing rates were quantified via Hedges’ g. Results: We quantified the effects of zolpidem, a positive modulator of GABA(A) receptors harboring α1-subunits, and the experimental benzodiazepine SH-053-2′F-S-CH3, which preferably acts at α2/3/5- but spares α1-subunits. Both agents decreased spontaneous action potential activity but altered the firing patterns in different ways. Zolpidem reduced action potential firing during highly active network states. This action was abolished by flumazenil, suggesting that it was mediated by benzodiazepine-sensitive GABA(A) receptors. SH-053-2′F-S-CH3 also attenuated neuronal activity, but unlike zolpidem, failed to reduce high frequency firing. To confirm that zolpidem actions were indeed mediated via α1-dependent actions, it was evaluated in slices from wild type and α(H101R) knock-in mice. Inhibition of high frequency action potential firing was observed in slices from wild type but not mutant mice. Conclusion: Our results suggest that during episodes of scarce and high neuronal activity action potential firing of cortical neurons is controlled by different GABA(A) receptor subtypes. Exaggerated firing of cortical neurons is reduced by positive modulation of α1-, but not α2/3/5-subunit containing GABA(A) receptors. Frontiers Media S.A. 2019-01-09 /pmc/articles/PMC6333667/ /pubmed/30687091 http://dx.doi.org/10.3389/fphar.2018.01523 Text en Copyright © 2019 Neumann, Rudolph, Knutson, Li, Cook, Hentschke, Antkowiak and Drexler. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Neumann, Elena Rudolph, Uwe Knutson, Daniel E. Li, Guanguan Cook, James M. Hentschke, Harald Antkowiak, Bernd Drexler, Berthold Zolpidem Activation of Alpha 1-Containing GABA(A) Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons |
title | Zolpidem Activation of Alpha 1-Containing GABA(A) Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons |
title_full | Zolpidem Activation of Alpha 1-Containing GABA(A) Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons |
title_fullStr | Zolpidem Activation of Alpha 1-Containing GABA(A) Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons |
title_full_unstemmed | Zolpidem Activation of Alpha 1-Containing GABA(A) Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons |
title_short | Zolpidem Activation of Alpha 1-Containing GABA(A) Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons |
title_sort | zolpidem activation of alpha 1-containing gaba(a) receptors selectively inhibits high frequency action potential firing of cortical neurons |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333667/ https://www.ncbi.nlm.nih.gov/pubmed/30687091 http://dx.doi.org/10.3389/fphar.2018.01523 |
work_keys_str_mv | AT neumannelena zolpidemactivationofalpha1containinggabaareceptorsselectivelyinhibitshighfrequencyactionpotentialfiringofcorticalneurons AT rudolphuwe zolpidemactivationofalpha1containinggabaareceptorsselectivelyinhibitshighfrequencyactionpotentialfiringofcorticalneurons AT knutsondaniele zolpidemactivationofalpha1containinggabaareceptorsselectivelyinhibitshighfrequencyactionpotentialfiringofcorticalneurons AT liguanguan zolpidemactivationofalpha1containinggabaareceptorsselectivelyinhibitshighfrequencyactionpotentialfiringofcorticalneurons AT cookjamesm zolpidemactivationofalpha1containinggabaareceptorsselectivelyinhibitshighfrequencyactionpotentialfiringofcorticalneurons AT hentschkeharald zolpidemactivationofalpha1containinggabaareceptorsselectivelyinhibitshighfrequencyactionpotentialfiringofcorticalneurons AT antkowiakbernd zolpidemactivationofalpha1containinggabaareceptorsselectivelyinhibitshighfrequencyactionpotentialfiringofcorticalneurons AT drexlerberthold zolpidemactivationofalpha1containinggabaareceptorsselectivelyinhibitshighfrequencyactionpotentialfiringofcorticalneurons |